UBS Starts DENTSPLY International (XRAY) at Neutral; Defensive Nature Represented

UBS initiates coverage on DENTSPLY International (NASDAQ: XRAY) with a Neutral. PT $41.00.

Analyst, Steven Valiquette, said, "On the positive side, XRAY, as a virtual dental consumables manufacturing pure-play, tends to be more defensive in nature vs. other public U.S. dental companies (Patternson (Nasdaq: PDCO) /Henry Schein (Nasdaq: HSIC) / Sirona (Nasdaq: SIRO)). These companies have more exposure to more volatile dental equipment markets, which can turn downward quickly when economies soften. Thus, we feel XRAY deserves some premium for defensiveness in this environment, but this seems already reflected in the current 10x EBITDA valuation."

For an analyst ratings summary and ratings history on DENTSPLY International click here. For more ratings news on DENTSPLY International click here.

Shares of DENTSPLY International closed at $37.91 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies Starts Busy Ming Group (1768:HK) at Buy
• Truist Securities Starts Oklo (OKLO) at Hold
• JPMorgan Starts Banco de Sabadell SA (SAB:SM) (BNDSF) at Underweight